These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3117469)

  • 1. [Clinical significance of the presence of precipitating antibodies against extractable nuclear antigens in sera of patients with polymyositis].
    Wada F
    Rinsho Shinkeigaku; 1987 Jul; 27(7):904-10. PubMed ID: 3117469
    [No Abstract]   [Full Text] [Related]  

  • 2. Antinuclear antibody with distinct specificity for polymyositis.
    Wolfe JF; Adelstein E; Sharp GC
    J Clin Invest; 1977 Jan; 59(1):176-8. PubMed ID: 318657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fluorescence anti-nuclear antibodies (FANA), using cultured human skin fibroblasts as substrate--clinical significance in polymyositis (PM)].
    Yoshimoto Y
    Ryumachi; 1988 Aug; 28(4):214-21. PubMed ID: 3055346
    [No Abstract]   [Full Text] [Related]  

  • 4. [The principle antinuclear and anti-cytoplasmic antibodies in polymyositis and dermatomyositis. Study of 42 cases].
    Meyer O; Cremer-Legmann F; Haim T; Ryckewaert A
    Presse Med; 1987 Feb; 16(4):155-8. PubMed ID: 2950445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Jo-1 antibody system in myositis: relationships to clinical features and HLA.
    Arnett FC; Hirsch TJ; Bias WB; Nishikai M; Reichlin M
    J Rheumatol; 1981; 8(6):925-30. PubMed ID: 6977032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies against a specific nuclear RNP protein in sera of patients with autoimmune rheumatic diseases associated with myositis.
    Arad-Dann H; Isenberg DA; Shoenfeld Y; Offen D; Sperling J; Sperling R
    J Immunol; 1987 Apr; 138(8):2463-8. PubMed ID: 3494067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody to Jo-1 in polymyositis/dermatomyositis: association with interstitial pulmonary disease.
    Hochberg MC; Feldman D; Stevens MB; Arnett FC; Reichlin M
    J Rheumatol; 1984 Oct; 11(5):663-5. PubMed ID: 6334746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and serologic features of patients with polymyositis or dermatomyositis.
    Holden DJ; Brownell AK; Fritzler MJ
    Can Med Assoc J; 1985 Mar; 132(6):649-53. PubMed ID: 3872156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies to nuclear antigens in polymyositis: relationship to autoimmune 'overlap syndromes' and carcinoma.
    Venables PJ; Mumford PA; Maini RN
    Ann Rheum Dis; 1981 Jun; 40(3):217-23. PubMed ID: 6787993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunological aspects of polymyositis].
    Takayanagi T; Honda H
    No To Shinkei; 1983 Jun; 35(6):525-33. PubMed ID: 6354219
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical significance of determining anti-extractable nuclear antigen in subjects with immunofluorecent negative anti-nuclear antibodies].
    Sakai H; Katayama Y; Haranou Y
    Rinsho Byori; 1989 Feb; 37(2):159-63. PubMed ID: 2499708
    [No Abstract]   [Full Text] [Related]  

  • 12. [Determination of anti polymyositis-1 antibody and its clinical significance].
    Jiang M; Song QF; Yuan X
    Zhonghua Nei Ke Za Zhi; 1988 Jul; 27(7):427-8, 455. PubMed ID: 3265373
    [No Abstract]   [Full Text] [Related]  

  • 13. [Significance of anti-centromere antibodies. Clinical value].
    Meyer O; Haim T; Ryckewaert A
    Rev Rhum Mal Osteoartic; 1983 Apr; 50(4):261-6. PubMed ID: 6348931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interstitial lung disease as the presentation of anti-Jo-1 positive polymyositis.
    Nash P; Schrieber L; Webb J
    Clin Rheumatol; 1987 Jun; 6(2):282-6. PubMed ID: 3497760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to extractable nuclear antigens in rheumatoid arthritis: relationship to vasculitis and circulating immune complexes.
    Venables PJ; Erhardt CC; Maini RN
    Clin Exp Immunol; 1980 Jan; 39(1):146-53. PubMed ID: 6771070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antibodies against soluble nuclear antigens of the SS-A or SS-B type. Significance in systemic lupus erythematosis (author's transl)].
    Meyer O; Haim T
    Nouv Presse Med; 1981 Jun; 10(26):2179-84. PubMed ID: 6973748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Polymyositis induced by D-penicillamine treatment of rheumatoid arthritis: apropos of 2 cases with antinuclear antibodies].
    Masson CJ; Ménard HA; Audran M; Renier JC; Lussier A; Myhal DM
    Union Med Can; 1986 Dec; 115(12):855-9. PubMed ID: 3492802
    [No Abstract]   [Full Text] [Related]  

  • 18. The PM-1 antibody test in a patient with rheumatic complaints.
    Solomon SD
    J Rheumatol; 1982; 9(1):157-8. PubMed ID: 6979627
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical implications of autoantibody screening in patients with autoimmune myositis.
    Ghirardello A; Zampieri S; Tarricone E; Iaccarino L; Bendo R; Briani C; Rondinone R; Sarzi-Puttini P; Todesco S; Doria A
    Autoimmunity; 2006 May; 39(3):217-21. PubMed ID: 16769655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antinuclear and anticytoplasmic antibodies in polymyositis and dermatomyositis].
    Nishikai M; Sugimoto M; Sato A
    Nihon Naika Gakkai Zasshi; 1986 Nov; 75(11):1597-601. PubMed ID: 3493313
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.